People: Quest Diagnostics Inc (DGX.N)
DGX.N on New York Stock Exchange
101.35USD
3:41pm EDT
101.35USD
3:41pm EDT
Change (% chg)
$0.20 (+0.20%)
$0.20 (+0.20%)
Prev Close
$101.15
$101.15
Open
$101.10
$101.10
Day's High
$102.05
$102.05
Day's Low
$100.62
$100.62
Volume
123,523
123,523
Avg. Vol
293,573
293,573
52-wk High
$112.83
$112.83
52-wk Low
$90.21
$90.21
Ring, Timothy
Mr. Timothy M. Ring is Independent Director of the Company. He has been Chairman and Chief Executive Officer of C. R. Bard, Inc. since 2003. He is a director of C. R. Bard, Inc. and was director of CIT Group Inc. from 2005 to 2009. Mr. Ring is a Trustee of the New Jersey Health Foundation.
Basic Compensation
| Total Annual Compensation, USD | 123,500 |
| Restricted Stock Awards, USD | 167,950 |
| Long-Term Incentive Plans, USD | -- |
| All Other, USD | -- |
| Fiscal Year Total, USD | 291,450 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Exercisable | -- | -- |
| Unexercisable | -- | -- |
| Exercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Stephen Rusckowski |
10,252,600 |
Mark Guinan |
3,234,610 |
James Davis |
3,053,960 |
Michael Prevoznik |
2,090,390 |
Jon Cohen |
2,491,990 |
Everett Cunningham |
-- |
As Of
30 Dec 2016